Fig. 1
Design strategy for 1-phenyl-β-carboline-3- carboxamide-1,2,3-triazole-N-phenylacetamide derivatives as new α-glucosidase inhibitors.
Fig. 1 | Scientific Reports
Design strategy for 1-phenyl-β-carboline-3- carboxamide-1,2,3-triazole-N-phenylacetamide derivatives as new α-glucosidase inhibitors.
